CNR1 and schizophrenia: The important role of the A2AR-CB1R heteromer in the inhibitory control of corticostriatal glutamate release makes it a potential target for neuropsychiatric disorders putatively associated with increased corticostriatal transmission, which includes obsessive-compulsive disorder [58], schizophrenia [59], and substance use disorders [60].